Simultaneous Catecholaminergic Polymorphic Ventricular Tachycardia and Long QT Syndrome Gene Mutations.

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Arrhythmology

Background:

• Genetic channelopathies predispose individuals to life-threatening cardiac arrhythmias.
• Long QT syndrome (LQTS) and catecholaminergic polymorphic ventricular tachycardia (CPVT) are distinct genetic channelopathies.
• Accurate genetic diagnosis is crucial for managing these conditions.

Observation:

• A patient presented with clinical features suggestive of a genetic channelopathy.
• Genetic analysis revealed novel, combined mutations in the KCNH2 and cardiac ryanodine receptor (RYR2) genes.
• This represents the first reported case of LQTS associated with this specific dual mutation.

Findings:

• Identification of a novel compound heterozygous mutation in KCNH2.
• Discovery of a novel mutation in the RYR2 gene.
• The combined mutations in KCNH2 and RYR2 were associated with a diagnosis of Long QT syndrome.

Implications:

• This case expands the known genetic landscape of Long QT syndrome.
• Highlights the importance of comprehensive genetic testing in complex arrhythmia cases.
• May inform future diagnostic strategies and therapeutic approaches for inherited arrhythmia syndromes.